Therapeutic inhibition of HBsAg and HBV cccDNA through a novel phased combination treatment: glycine and interferon-alpha. Lin C, Huang Y, Ran N, Liu J, et al. Gut 2025;74:2035-2049.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lin C, Huang Y, Ran N, Liu J, et al. Therapeutic inhibition of HBsAg and HBV cccDNA through a novel phased combination treatment: glycine and interferon-alpha. Gut 2025;74:2035-2049.
PMID: 40645766